Dimension Therapeutics, Inc. Patent Applications Rejected
1 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2019-01-09: Application 16316426; Invention USE OF GLUCOCORTICOID ANALOGS TO ENHANCE RECOMBINANT ADENO-ASSOCIATED VIRUS YIELD; Applicant Dimension Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2019-01-09 | 16316426 | USE OF GLUCOCORTICOID ANALOGS TO ENHANCE RECOMBINANT ADENO-ASSOCIATED VIRUS YIELD | Dimension Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190290710A1 | Ying Jing Mingyang Jiang Kelly Reed Clark | United States United States United States | CHEN, SHIN LIN |